4//SEC Filing
BIOGEN IDEC INC. 4
Accession 0001127602-13-032763
$BIIBCIK 0000875045operating
Filed
Nov 24, 7:00 PM ET
Accepted
Nov 25, 2:11 PM ET
Size
8.4 KB
Accession
0001127602-13-032763
Insider Transaction Report
Form 4
BIOGEN IDEC INC.BIIB
Pawlicki Raymond
SVP, Chief Information Officer
Transactions
- Exercise/Conversion
Common Stock
2013-11-22$49.95/sh+4,000$199,800→ 12,710.378 total - Sale
Common Stock
2013-11-22$288.00/sh−4,000$1,152,000→ 8,710.378 total - Exercise/Conversion
Stock Option (Right to Buy)
2013-11-22−4,000→ 4,480 totalExercise: $49.59Exp: 2018-10-01→ Common Stock (4,000 underlying)
Footnotes (2)
- [F1]Exercise/sale pursuant to a trading plan intended to comply with Rule 10b5-1 of the Securities Exchange Act of 1934.
- [F2]The stock options vest in four (4) equal annual installments commencing one year after the grant date of 10/01/08.
Documents
Issuer
BIOGEN IDEC INC.
CIK 0000875045
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000875045
Filing Metadata
- Form type
- 4
- Filed
- Nov 24, 7:00 PM ET
- Accepted
- Nov 25, 2:11 PM ET
- Size
- 8.4 KB